Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ryzodeg®
Clinical trial NCT02821052 · COMPLETED
Trial details
- NCT number
- NCT02821052
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-07-01
- Primary completion
- 2018-11-24
- Enrollment
- 1355
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.